Cancer ResearchResearch PaperPaywall

Desert Plant Extract Triggers Senescence and Blocks Autophagy in Triple-Negative Breast Cancer Cells

A UAE plant used in folk medicine shows potent anti-cancer activity against hard-to-treat triple-negative breast cancer in lab studies.

Monday, July 6, 2026 1 view
Published in Sci Rep
A laboratory bench with a glass flask containing a dark amber plant extract alongside breast cancer cell culture dishes under a microscope, scientific equipment in background

Summary

Researchers from UAE University tested an ethanolic extract from Acridocarpus orientalis, a plant used in traditional folk medicine, against three breast cancer cell lines, including two triple-negative breast cancer types. Triple-negative breast cancer is notoriously difficult to treat because it lacks the receptors targeted by hormonal therapies. The extract significantly slowed cancer cell growth by halting the cell cycle, inducing a form of cellular aging called senescence, and triggering a blocked or "abortive" autophagy process where cells begin self-cleanup but cannot complete it. Key molecular markers of cell cycle control were altered, and stress-response pathways were activated. These early laboratory findings suggest the plant could be a source of novel anti-cancer compounds.

Detailed Summary

Triple-negative breast cancer remains one of the most challenging cancers to treat. Unlike hormone receptor-positive or HER2-positive breast cancers, TNBC lacks the molecular targets exploited by standard hormonal therapies, leaving chemotherapy and radiation as primary options — both of which carry significant side-effect burdens. Finding plant-derived compounds that can selectively inhibit TNBC cell growth is an active and promising area of research.

Researchers at UAE University investigated Acridocarpus orientalis, a plant with a history in regional folk medicine, by preparing an ethanolic extract (AOEE) and testing it on two TNBC cell lines (MDA-MB-231 and Hs578T) as well as one luminal A breast cancer line (MCF-7). They assessed proliferation, cell cycle dynamics, and the molecular pathways involved.

The extract inhibited proliferation across all three cell lines in a dose- and time-dependent manner. It arrested the cell cycle at the G1/S checkpoint, accompanied by upregulation of the tumor suppressor proteins p21 and p27, and downregulation of Cyclin D1, PCNA, and phosphorylated Rb — all hallmarks of cell cycle brake activation. Additionally, AOEE induced "abortive autophagy," a state in which autophagy is initiated but not completed, as evidenced by elevated LC3-II, Beclin-1, and p62 simultaneously. In MDA-MB-231 cells specifically, p16-dependent cellular senescence was confirmed through beta-galactosidase staining. ERK and p38 signaling pathways were also activated, likely mediating these effects.

The findings position Acridocarpus orientalis as a potentially valuable source of anti-cancer compounds. The dual induction of senescence and abortive autophagy represents a mechanistically interesting approach to stalling cancer growth. However, all experiments were conducted in cell culture only, and no animal or human data exist yet. The summary is based on the abstract alone, and full mechanistic detail awaits open-access review.

Key Findings

  • AOEE suppressed proliferation in all three breast cancer cell lines in a dose- and time-dependent manner.
  • Cell cycle arrest at G1/S was confirmed with upregulation of p21 and p27 and downregulation of Cyclin D1.
  • Abortive autophagy was triggered, with simultaneous elevation of LC3-II, Beclin-1, and p62.
  • p16-dependent senescence was confirmed in MDA-MB-231 TNBC cells via beta-galactosidase staining.
  • ERK and p38 stress pathways were activated, potentially driving both senescence and autophagy disruption.

Methodology

In vitro study using two TNBC cell lines (MDA-MB-231, Hs578T) and one luminal A line (MCF-7) treated with an ethanolic extract of Acridocarpus orientalis. Endpoints included proliferation assays, cell cycle analysis, western blotting for molecular markers, and senescence-associated beta-galactosidase staining. No animal or human studies were conducted.

Study Limitations

All findings are from in vitro cell-line experiments only; no animal model or human data support clinical conclusions. The active phytochemical constituents of the extract have not been identified or isolated. This summary is based on the abstract only, as the full text was not accessible.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: